Cargando…
Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease
GOAL: To determine the effect of the specific carbohydrate diet (SCD) on active inflammatory bowel disease (IBD). BACKGROUND: IBD is a chronic idiopathic inflammatory intestinal disorder associated with fecal dysbiosis. Diet is a potential therapeutic option for IBD based on the hypothesis that chan...
Autores principales: | Suskind, David L., Cohen, Stanley A., Brittnacher, Mitchell J., Wahbeh, Ghassan, Lee, Dale, Shaffer, Michele L., Braly, Kimberly, Hayden, Hillary S., Klein, Jani, Gold, Benjamin, Giefer, Matthew, Stallworth, Angela, Miller, Samuel I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health, Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484760/ https://www.ncbi.nlm.nih.gov/pubmed/28030510 http://dx.doi.org/10.1097/MCG.0000000000000772 |
Ejemplares similares
-
The natural history of COVID-19 in vaccinated inflammatory bowel disease patients
por: Viazis, N., et al.
Publicado: (2023) -
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study
por: Ianiro, Gianluca, et al.
Publicado: (2020) -
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population
por: Maconi, Giovanni, et al.
Publicado: (2021) -
Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group
por: Arrigo, Serena, et al.
Publicado: (2021) -
Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs
por: Bossa, Fabrizio, et al.
Publicado: (2021)